Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fast-Growing China Pharma Industry Still Has Long Way To Go: Experts

This article was originally published in PharmAsia News

Executive Summary

China's pharmaceutical industry is growing rapidly and attracting foreign companies interested in innovative drugs, but it is still at a nascent stage, according to some experts.

China's pharmaceutical industry is growing rapidly and attracting foreign companies interested in innovative drugs, but it is still at a nascent stage, according to some experts. One biotechnology analyst said China still lags far behind in innovative content, but an academic expert said the huge investments in the industry would come together eventually as multinational drug makers continue to focus on the nation's potential. Another academic expert estimated China is five to 10 years from having a local pharma industry that begins to look like that of the U.S. (Click here for more)

"China's Big Pharma Makes Strides" - Shanghai Daily (China) (4/22/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC084091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel